(Total Views: 616)
Posted On: 05/13/2024 4:23:06 PM
Post# of 156265
Hypothetically speaking if there was a buyout. Is it possible to have a buyout for just one indication. Let’s say someone paid 10 billion for all the rights to NASH. Has anything like this ever been done?
Obviously I don’t think this is happening but I’m talking after a good phase 3 trial results could a company buy the rights to one indiction and we continue business as normal.
Obviously I don’t think this is happening but I’m talking after a good phase 3 trial results could a company buy the rights to one indiction and we continue business as normal.


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com